NanoSphere Health Sciences Inc.
NSHS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 42.70K | 42.70K | 39.40K | 50.40K | 28.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.70K | 42.70K | 39.40K | 50.40K | 31.90K |
| Operating Income | -42.70K | -42.70K | -39.40K | -50.40K | -31.90K |
| Income Before Tax | -47.20K | -47.20K | 38.70K | -9.50K | -14.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.20K | -47.20K | 38.70K | -9.50K | -14.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.20K | -47.20K | 38.70K | -9.50K | -14.10K |
| EBIT | -42.70K | -42.70K | -39.40K | -50.40K | -31.90K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 10.28M | 10.28M | 10.28M | 10.28M | 10.28M |
| Average Diluted Shares Outstanding | 10.28M | 10.28M | 10.28M | 10.28M | 10.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |